Debiopharm finalizes a strategic partnership to leverage WhiteLab’s proprietary AI platform for identifying agents that provide targeting properties to non-viral vectors in oncology.
Debiopharm, a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, announced the signing of a partnership with WhiteLab Genomics (WLG),...
Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and free portal designed to help cancer patients navigate their clinical trial journey across the globe.
Massive Bio Patient Connect empowers patients and simplifies their search for...
Anervea.ai, a global leader in AI-powered commercialization solutions for the Pharmaceutical, Life Sciences, and Biotech industries, is pleased to announce the appointment of Jack Capponi as Chief Commercial Officer (CCO) and a member of the Board of Directors. Jack's expertise, combined with Anervea's deep tech capabilities in AI, machine learning (ML), and data science, positions the...
Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. announced a strategic collaboration to increase patient access to cutting edge clinical trials. This collaboration unites Massive Bio’s patient matching technology and last-mile solutions with Foundation Medicine’s global expertise and leadership in next generation...
Turbine has successfully completed the first phase of its oncology target identification and validation collaboration with Ono
Turbine, the biological simulation company using AI to build a digital lab for predictive computational models of human cells and tissue, announced that Ono Pharmaceutical Co., Ltd. has selected multiple targets identified using...
NOETIK, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced that it has been selected for the second cohort of the AWS Generative AI Accelerator. Launched by Amazon Web Services, Inc. (AWS), the AWS Generative AI Accelerator identifies top early-stage...
Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced the latest capabilities of its AdaptV platform to increase the efficiency and success rates of oncology clinical trials. AdaptV is an interactive machine learning-based simulation...
Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest diagnostics and life sciences companies in the world. This collaboration represents a significant milestone to advance cancer diagnostics and treatment and accelerate adoption of AI by pathologists.
With...
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), announced a collaboration with 3P innovation, a leading engineering company and supplier of automated fill-finish equipment....
CustomerInsights.AI has once again been recognized in the Gartner Hype Cycle for Life Science Commercial Operations, 2024. This marks the second consecutive year CustomerInsights.AI has been included in the Data and Analytics (D&A) Platforms in Commercial Life Sciences category. We believe, this recognition underscores our commitment to pioneering advancements...
